Sebastian Göbel Selected Research

Heart Failure

10/2022	Successful treatment of doxorubicin-induced cardiomyopathy with low-dose sacubitril/valsartan: a case report.
10/2022	Telomere Shortening in Hypertensive Heart Disease Depends on Oxidative DNA Damage and Predicts Impaired Recovery of Cardiac Function in Heart Failure.
1/2021	Association of Global Longitudinal Strain With Clinical Status and Mortality in Patients With Chronic Heart Failure.
1/2021	Rationale, design and baseline characteristics of the MyoVasc study: A prospective cohort study investigating development and progression of heart failure.
7/2019	Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism.
11/2018	Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sebastian Göbel Research Topics

Disease

6	Heart Failure 10/2022 - 11/2018
4	Hemorrhage 01/2022 - 12/2018
3	Neoplasms (Cancer) 10/2022 - 01/2021
2	Myocarditis (Carditis) 01/2022 - 01/2020
2	Atrial Fibrillation 08/2019 - 12/2018
2	Inflammation (Inflammations) 01/2018 - 01/2017
1	Hemangiosarcoma (Angiosarcoma) 10/2022
1	Cardiomyopathies (Cardiomyopathy) 10/2022
1	Pain (Aches) 10/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Death (Near-Death Experience) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2020
1	Chronic Renal Insufficiency 02/2020
1	COVID-19 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2019
1	Vascular Diseases (Vascular Disease) 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Thromboembolism 05/2015
1	Mental Disorders (Mental Disorder) 01/2015
1	Obesity 01/2015
1	Frailty 01/2015
1	Infarction (Infarctions) 07/2009

Drug/Important Bio-Agent (IBA)

4	Vitamin K FDA Link 07/2019 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 07/2019
2	C-Reactive ProteinIBA 01/2018 - 01/2017
1	Spironolactone (Aldactone)FDA LinkGeneric 10/2022
1	Ramipril (Altace)FDA LinkGeneric 10/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2022
1	Torsemide (Demadex)FDA LinkGeneric 10/2022
1	pazopanib FDA Link 10/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2022
1	Carvedilol (Coreg)FDA LinkGeneric 10/2022
1	Superoxides (Superoxide)IBA 10/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Factor Xa InhibitorsIBA 07/2019
1	Atrial Natriuretic Factor (ANF)IBA 01/2018
1	AdrenomedullinIBA 01/2018
1	Fibrinogen (Factor I)FDA Link 01/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2017
1	Hypnotics and Sedatives (Sedatives)IBA 01/2015
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2015
1	Antidepressive Agents (Antidepressants)IBA 01/2015
1	antineoplaston A10 (A 10)IBA 01/2015
1	Nitroglycerin (Dynamite)FDA LinkGeneric 07/2009

Therapy/Procedure

8	Therapeutics 10/2022 - 05/2015
2	Radiotherapy 10/2022 - 01/2021
1	Heart Transplantation (Grafting, Heart) 01/2022
1	Cardiopulmonary Resuscitation (CPR) 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 09/2020
1	Polypharmacy 01/2019